Recombinant Technologies

Revolutionary Alzheimer's Treatment

Analytics

Raised to Date: Raised: $22,508

Aggregate Commitments $
Platform

StartEngine

Start Date

07/15/2021

Close Date

01/12/2022

Min. Goal

$10,000

Max. Goal

$1,070,000

Min. Investment

$200

Security Type

Equity - Common

Funding Type

RegCF

Pre-Money Valuation

$35,000,000

Rolling Commitments $
Status

Active

Reporting Date

07/28/2021

Days Remaining

168

% of Min. Goal

225%

% of Max. Goal

2%

Likelihood of Max
unlikely
Avg. Daily Raise

$1,731

# of Investors

45

Momentum
cool
Log in or create a free account today to gain access to KingsCrowd analytics.
Location

Cheshire, Connecticut

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Recombinant Technologies, with a pre-money valuation of $35 million, is raising crowdfunding on StartEngine. The company is developing a revolutionary treatment for Alzheimer’s Disease. It is designing a process of injecting a molecule into the patients to reduce the plaque buildup that causes dementia. Dr. Pazhani Sundaram founded Recombinant Technologies in May 2021. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,070,000, and the proceeds will be used to complete the studies to get the FDA approval of the device. Recombinant Technologies’ patented technology was developed with $4.5 million in grants and has been shown to improve memory in mice.
Log in or create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Staff Picks (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including Merlin ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by Merlin ratings
Company specific Merlin rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Analyst Report

Other Deals

Cheers on StartEngine

Alcohol consumption is one of the oldest human practices on record. A study released in…

RegCF
EnGen Bio on Wefunder

COVID-19 has brought the world’s attention to vaccine development. In April 2021, a record 4

RegCF
Audubon Bioscience on MicroVentures

In 2020 alone, companies produced, tested, and began to produce a vaccine for a completely new virus on…

RegCF
Create your first portfolio
WELCOME TO YOUR OWN INVESTMENTS PORTFOLIO ON KINGSCROWD.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add Recombinant Technologies on StartEngine 2021
Follow company
Follow Recombinant Technologies on StartEngine 2021
Want to learn more about Recombinant Technologies?
Join the Pre-IPO Market’s #1 Ratings & Analytics Service FREE for 7 days.
Yes! I want to start my free trial.
Already a member? Log in here.
Invest Now